Genomic Health Newswire (Page 4)

Comprehensive Real-Time News Feed for Genomic Health. (Page 4)

Results 61 - 80 of 108 in Genomic Health

  1. Genomic Health to Present at Two Upcoming Investor ConferencesRead the original story

    May 23, 2014 | Freshnews

    REDWOOD CITY, Calif., May 23, 2014 /PRNewswire/ -- Genomic Health, Inc. today announced that members of its management team will present at the following conferences in June: -- Jefferies 2014 Global Healthcare Conference on Monday, June 2 at 4:00 p.m. Eastern Time in New York City; and -- Goldman Sachs 35 Annual Global Healthcare Conference on ... (more)

    Comment?

  2. Genomic Health's Oncotype DX Becomes First Multi-Gene Test for...Read the original story

    May 22, 2014 | Hispanic Business

    Comprehensive scientific and clinical information about the Oncotype DX breast cancer test is now incorporated in the GTR database, representing leadership in applying genomic information to make cancer care smarter.

    Comment?

  3. Genomic Health Announces Data Reinforcing Robustness of Oncotype DXA ...Read the original story

    May 20, 2014 | Freshnews

    Genomic Health, Inc. today presented positive results reinforcing the robustness of the Oncotype DX prostate cancer test's development as a predictor of prostate cancer aggressiveness.

    Comment?

  4. Genomic Health announces data reinforcing robustness of Oncotype DXRead the original story

    May 6, 2014 | Theflyonthewall.com

    Genomic Health announces data reinforcing robustness of Oncotype DX Genomic Health presented positive results reinforcing the robustness of the Oncotype DX prostate cancer test's development as a predictor of prostate cancer aggressiveness.

    Comment?

  5. European Urology Published Groundbreaking Results from Three Studies...Read the original story

    May 16, 2014 | Freshnews

    Genomic Health, Inc. announced today that groundbreaking results from three studies of the Oncotype DX prostate cancer test were published in European Urology.

    Comment?

  6. European Urology Published Groundbreaking Results from Three Studies...Read the original story

    May 16, 2014 | Applied Clinical Trials

    ... Increases Number of Low-Risk Patients Who Can Confidently Choose Active Surveillance /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) announced today that groundbreaking results from three studies of the Oncotype DX prostate cancer test were ...

    Comment?

  7. W2O Groupa s BrewLife Reports 2013 Business Results and HighlightsRead the original story

    May 15, 2014 | Business Wire

    ... companies with branding and communications support Won 3 DxMA awards: Two Gold (for the Singulex website and Genomic Health prostate website) and one Silver (for the Aptus brand campaign) Part of W2O Group, BrewLife is an integrated brand ...

    Comment?

  8. DxMA Global Marketing Summit Draws Leaders in Diagnostics to San...Read the original story

    May 14, 2014 | PRWeb

    ... These presentations will be made available to DxMA members in July 2014. The 2013 Marketer of the Year , Genomic Health, kicked off the Global Marketing Summit with a presentation made by their President, CEO and Chairman of the Board, Kimberly J. ...

    Comment?

  9. Story ImageRead the original story

    May 7, 2014 | Western Wheel

    ... taken during her second lumpectomy, and paid the $4,000 out of her own pocket to have the sample sent to the Genomic Health Inc. laboratory in California where the test is performed. Beaulne received good news from the test, with a low recurrence ...

    Comment?

  10. Story ImageRead the original story

    May 7, 2014 | Western Wheel

    ... taken during her second lumpectomy, and paid the $4,000 out of her own pocket to have the sample sent to the Genomic Health Inc. laboratory in California where the test is performed. Beaulne received good news from the test, with a low recurrence ...

    Comment?

  11. Genomic Health Hits New 12-Month Low at $24.50Read the original story

    May 5, 2014 | AmericanBankingNews.com

    Genomic Health 's share price reached a new 52-week low on Monday , AnalystRatings.Net reports.

    Comment?

  12. Genomic Health Announces Presentation of Multiple Oncotype DX?...Read the original story

    May 5, 2014 | Applied Clinical Trials

    Genomic Health Announces Presentation of Multiple Oncotype DX? Studies in Breast, Prostate, Colon and Renal Cancers at the American Society of Clinical Oncology Annual Meeting New Data Include Results on Oncotype DX's Prognosis of Late Recurrence in Invasive Breast Cancer and Clinical Utility in Ductal Carcinoma In Situ Genomic Health Announces ... (more)

    Comment?

  13. Oncotype DX? Changes Treatment Decisions in 45 Percent of Stage II Colon Cancer PatientsRead the original story

    May 2, 2014 | Applied Clinical Trials

    /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that The Oncologist published positive results from an Oncotype DX colon cancer decision impact study, demonstrating that Recurrence Score results changed treatment recommendations ...

    Comment?

  14. Genomic Health (GHDX) Scheduled to Post Earnings on ThursdayRead the original story

    Apr 30, 2014 | AmericanBankingNews.com

    Genomic Health last posted its quarterly earnings results on Tuesday, February 4th.

    Comment?

  15. Companion Diagnostics Market Is Growing at CAGR of 18.1% from 2013 to ...Read the original story

    Apr 30, 2014 | SBWire

    ... competing in this market are Roche Holdings AG, Qiagen N.V., Abbott Laboratories, Agilent Technologies, Inc., Genomic Health, Inc., GE Healthcare Ltd., Life Technologies Corporation, and Agendia N.V. The global companion diagnostics market is ...

    Comment?

  16. Global genetic testing market: 9% CAGR forecast between 2012-2016Read the original story w/Photo

    Apr 28, 2014 | PR-inside.com

    ... The other vendors mentioned in the report are Agilent Technologies Inc., bioMA rieux SA, Clarient Inc., Genomic Health Inc., Hologenic Inc., Myriad Genetics Inc., Sequenom Inc., and Transgenomic Inc. Click for report details: ...

    Comment?

  17. Genomic Health, Inc. (GHDX) - Pharmaceuticals & Healthcare - Deals...Read the original story

    Apr 23, 2014 | PR-inside.com

    2014-04-23 20:21:38 - Recently published research from GlobalData, "Genomic Health, Inc. (GHDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile", is now available at Fast Market Research Genomic Health, Inc. (Genomic Health) is a life ...

    Comment?

  18. Genomic Health Receives Consensus Rating of "Hold" from BrokeragesRead the original story

    Apr 23, 2014 | AmericanBankingNews.com

    Genomic Health has received a consensus recommendation of "Hold" from the fourteen ratings firms that are currently covering the company, American Banking News.com reports .

    Comment?

  19. B.C. latest province to fund special breast cancer treatment testRead the original story w/Photo

    Apr 22, 2014 | Canada.com

    ... ithin those patients, hormonal therapy was offered to 20 per cent; chemotherapy to the remaining 10 per cent. Genomic Health, Inc., based in Redwood City, Calif., says its test has been used on 420,000 patients in 70 countries.

    Comment?

  20. Genomic Health announces two important international milestonesRead the original story

    Apr 22, 2014 | Theflyonthewall.com

    Genomic Health announces two important international milestones Genomic Health announced two important international milestones including additional reimbursement in Canada and the inclusion of the Oncotype DX breast cancer test in major German clinical guidelines.

    Comment?